NecksGen Inc.
USPTO PatentsView assignee record - 5 granted patents across 3 technology areas, recorded in grant years 2016–2023. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A42B (HATS; Head Coverings).
The verdict
According to USPTO PatentsView, Necksgen ranks #49,005 of 49,997 tracked US assignees by granted-patent volume, with 5 patents across 3 technology areas.
- #49,005
- of 49,997 US assignees by volume
- 11th percentile
- by Innovation Score (23.1/100)
- 12.4
- avg claims per patent
- +50%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R49005 · US Corporation #49,005 · 5 grants
GRANTS-MICRO · BOTTOM-DECILE · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-SURGE · BOOK-FULL
- GRANTS-MICRO 5 grants
- BOTTOM-DECILE #49,005/49,997
- PHOTO-FINISH Navistar Canada
- CPC-NARROW A42B · 3 areas
- INNOV-THIN 23.1/100
- CLAIMS-RICH 12.4 claims/avg
- TYPE-USCORP US Corporation
- VEL-SURGE +50% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Navistar Canada, Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Necksgen’s 23.1 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Necksgen
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- NecksGen · this assignee 23
NecksGen · this assignee
23 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Necksgen's Innovation Score is 23.1/100 (11th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Necksgen?
Each dot is one of Necksgen’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Necksgen’s own 12.4 claims/patent is ABOVE the 12.0 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where Necksgen's grants concentrate
NecksGen Inc. is a focused PatentsView assignee: 3 CPC subclasses with 80% of grants classified under A42B (HATS; Head Coverings). By volume, Necksgen sits between Navistar Canada, Inc. and Neogenis Labs, Inc..
Necksgen's three-year grant acceleration
NecksGen Inc. shows 1 grants in 2022–2024 against only 2 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at NecksGen's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Navistar Canada
Navistar Canada, Inc.
5 patents
- Navitas Solutions
Navitas Solutions, Inc.
5 patents
- Nexolve Holding
NeXolve Holding Company, LLC
5 patents
- Near-miss Managem…
Near-Miss Management LLC
5 patents
- Nectero Medical
Nectero Medical, Inc
5 patents
- Neo Mechanics
Neo Mechanics Limited
5 patents
- Neodiagnostix
NeoDiagnostix, Inc.
5 patents
- Neogenis Labs
Neogenis Labs, Inc.
5 patents
- Necksgen ◀
NecksGen Inc.
5 patents
What this shows NecksGen holds 5 patents at rank #49,130, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near NecksGen
By rank, the assignees closest to #49,130 in granted patent volume.
- Navistar Canada, Inc. #49,126 · 5 patents
- Navitas Solutions, Inc. #49,127 · 5 patents
- NeXolve Holding Company, LLC #49,128 · 5 patents
- Near-Miss Management LLC #49,129 · 5 patents
- Nectero Medical, Inc #49,131 · 5 patents
- Neo Mechanics Limited #49,132 · 5 patents
- NeoDiagnostix, Inc. #49,133 · 5 patents
- Neogenis Labs, Inc. #49,134 · 5 patents
Leaders in A42B (HATS)
Other assignees with the most granted patents in NecksGen's primary technology class.
Necksgen's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
23 11th percentile higher than 11% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2016 | 1 | 20.0% |
| 2018 | 1 | 20.0% |
| 2020 | 1 | 20.0% |
| 2021 | 1 | 20.0% |
| 2023 | 1 | 20.0% |
Which technologies does NecksGen Inc. patent most?
Top 3 of 3 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
NecksGen Inc.'s patent record in context - here's where to go next.
- NecksGen Inc.'s lead technology class is A42B (HATS; Head Coverings), 80% of its portfolio - see every assignee active in that class. Explore A42B
- Ranked #49,005 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare NecksGen Inc. against Navistar Canada, Inc., an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 23.1/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.